InvestorsHub Logo
Followers 4
Posts 842
Boards Moderated 0
Alias Born 06/30/2017

Re: walterc post# 39530

Monday, 07/23/2018 4:37:37 PM

Monday, July 23, 2018 4:37:37 PM

Post# of 113459
This post is actually the basis for my concern. Not counting those internal to Niocorp or those working under Andrew Matheson at OnG commodities, to my knowledge this pricing was only set by two people. Andrew Matheson provided the study. Grant Malensek reviewed it.

Contrary to a commonly held belief on this board, all 15 qualified persons in the feasibility to study do not each review every section. The market studies are in section 19 of the study. Malensek was the only one that reviewed this section.

In fact, the Ontario Securities Commission specifically requested disclosure on the reliance of outside experts in the revision. Matheson's name is the only one listed in the section 3 disclosures. Also in section 3 is the disclosure "Niocorp's products may not command special chemical pricing."

In regards to your second point, I don't disagree with you, but again that is part of the basis for my concern. Niocorp, Scandium International, and Cleanteq are all pursuing alloy development with different partners. IBC is to Niocorp as Eck Industries is to Scandium International as Chinalco is to Cleanteq.

In other words, all three companies have extremely similar strategies, believe the scandium market growth potential comes from the same industries, and yet one of them is an outlier with their pricing predictions.

Here's a link to a video from SCY's CEO. I posted this a while back. If one simply read a transcript of this interview they could be lead to believe it was Mark Smith instead. The strategies are that similar.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NB News